Lydia Poole reviews a recent randomised controlled trial evaluating group metacognitive therapy for depression and anxiety in cardiac patients.
[read the full story...]
Peter Knapp and Suzy Ker review a recent study from Finland, which suggests that women with schizophrenia who take prolactin-increasing antipsychotics for at least five years, have an increased risk of developing breast cancer.
[read the full story...]
Lydia Poole reviews a recent Canadian study examining depression as a risk factor for physical illness and multimorbidity in a cohort with no prior comorbidity.
[read the full story...]
Dafni Katsampa explores a qualitative study carried out by researchers in the Netherlands, which finds that experiencing an injury from a traumatic event like a serious road traffic accident, can impact on physical, psychological and social wellbeing.
[read the full story...]
Dolly Sud appraises a recent data linkage study on the impact of schizophrenia genetic liability on the association between schizophrenia and physical illness.
[read the full story...]
Jonathan Monk-Cunliffe explores a recent cohort study which finds that people with inflammatory diseases such as multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease are at greater risk of “personality disorder”.
[read the full story...]
Shirley Reynolds reviews a records study which finds that around one third of children and young people who die by suicide have no explicit prior risk.
[read the full story...]
Tayla McCloud reviews a recent paper which finds that imposter syndrome might be at the heart of both poor wellbeing and high stress levels in PhD students.
[read the full story...]
Marco Solmi tells us about the importance of physical activity as people in the UK enter a second period of coronavirus lockdown.
He also introduces us to the huge international COH-FIT study, which will help us better understand how the pandemic is affecting people and what can help.
[read the full story...]
Masuma Mishu from the Closing the Gap Network reviews a recent US trial of a comprehensive cardiovascular risk reduction intervention in people with severe mental illness, which shows promising results.
[read the full story...]
